ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,173,000 | -34.2% | 38,655,000 | -29.6% | 0.01% | -25.0% |
| Q1 2022 | $38,255,000 | -15.9% | 54,905,000 | -9.5% | 0.01% | -11.1% |
| Q4 2021 | $45,465,000 | -2.5% | 60,655,000 | -7.6% | 0.01% | -10.0% |
| Q3 2021 | $46,617,000 | +7.3% | 65,655,000 | -1.5% | 0.01% | 0.0% |
| Q2 2021 | $43,446,000 | -2.5% | 66,655,000 | 0.0% | 0.01% | -9.1% |
| Q1 2021 | $44,578,000 | +15.2% | 66,655,000 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $38,695,000 | -9.9% | 66,655,000 | -1.5% | 0.01% | -16.7% |
| Q3 2020 | $42,941,000 | -6.2% | 67,655,000 | +6.3% | 0.01% | -25.0% |
| Q2 2020 | $45,781,000 | +46.9% | 63,655,000 | +13.0% | 0.02% | +14.3% |
| Q1 2020 | $31,159,000 | -20.4% | 56,350,000 | +12.4% | 0.01% | -17.6% |
| Q4 2019 | $39,152,000 | -6.6% | 50,150,000 | 0.0% | 0.02% | -15.0% |
| Q3 2019 | $41,940,000 | -7.6% | 50,150,000 | 0.0% | 0.02% | -4.8% |
| Q2 2019 | $45,386,000 | – | 50,150,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Indaba Capital Management, L.P. | 22,235,000 | $14,700,000 | 1.93% |
| PenderFund Capital Management Ltd. | 5,560,000 | $4,921,000 | 1.36% |
| Bruce & Co., Inc. | 3,000,000 | $2,040,000 | 0.48% |
| Saltoro Capital, LP | 2,000,000 | $1,360,000 | 0.33% |
| INGALLS & SNYDER LLC | 769,000 | $509,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 4,000,000 | $2,727,000 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 2,750,000 | $1,870,000 | 0.01% |
| Citadel Advisors | 38,655,000 | $25,173,000 | 0.01% |
| CREDIT SUISSE AG/ | 2,000,000 | $2,000,000 | 0.00% |
| JANE STREET GROUP, LLC | 3,000,000 | $1,971,000 | 0.00% |